Here you will find financial information related to Infant Bacterial Therapeutics AB.

The class B share of Infant Bacterial Therapeutics AB was listed on Nasdaq Stockholm First North on March 29, 2016 and approved to be listed on Nasdaq Stockholm First North Premier from March 14, 2017.

 

Certified Adviser

Erik Penser Bank

Apelbergsgatan 27
Box 7405
103 91 Stockholm

Phone: +46 (0)8 463 80 00